The identification of effective therapeutic modalities to manage lymphedema secondary to
cancer is a high priority among patients and clinicians. Complex decongestive therapy …

Breast cancer-related lymphedema (BCRL) is one of the most significant complications seen
after surgery. Several studies demonstrated that extracorporeal shock wave therapy (ESWT) …

Background We evaluated the effects of combined complex decongestive therapy (CDT)
with electrotherapy modalities (ultrasound and faradic currents) in patients with breast …

Extracorporeal shock wave therapy (ESWT) can reduce breast cancer-related lymphedema
(BCRL). However, evidence of the long-term effectiveness of ESWT on BCRL is sparse. The …

Background: Secondary lymphedema (LE) can occur after breast cancer (BC) therapy with
axillary lymph node surgery and/or radiotherapy. Reported incidence varies around 20 …

Lymphedema is one of the most dreaded complications related to breast cancer surgery,
commonly resulting in upper limb functional, esthetic, and psychological impairment. The …

Limfedema ekstremitas atas adalah komplikasi fisik yang biasa dialami setelah pengobatan
kanker payudara, ditandai dengan pembengkakan jaringan yang terus-menerus di …

Introduction: This expert review examines the evidence base for lymphedema management
and recommends ways to improve outcomes for breast cancer survivors at risk of and living …

Breast cancer is the most common type of cancer in women worldwide (J. Ferley et al.,
2015). Breast cancer-related lymphoedema (BCRL) is a disabling complication with a long …

BACKGROUND Breast cancer is one of the three most frequently diagnosed cancers among
women and is the most common cause of death in this population [1, 2]. It is estimated that …